nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—CYP2D6—Fingolimod—multiple sclerosis	0.148	0.261	CbGbCtD
Palonosetron—CYP3A4—Fingolimod—multiple sclerosis	0.0944	0.166	CbGbCtD
Palonosetron—HTR3A—area postrema—multiple sclerosis	0.0839	0.742	CbGeAlD
Palonosetron—CYP3A4—Methylprednisolone—multiple sclerosis	0.0608	0.107	CbGbCtD
Palonosetron—CYP3A4—Triamcinolone—multiple sclerosis	0.0461	0.0811	CbGbCtD
Palonosetron—CYP3A4—Mitoxantrone—multiple sclerosis	0.0444	0.078	CbGbCtD
Palonosetron—CYP3A4—Betamethasone—multiple sclerosis	0.0395	0.0695	CbGbCtD
Palonosetron—CYP3A4—Prednisolone—multiple sclerosis	0.039	0.0686	CbGbCtD
Palonosetron—CYP3A4—Prednisone—multiple sclerosis	0.0368	0.0648	CbGbCtD
Palonosetron—CYP2D6—Dexamethasone—multiple sclerosis	0.0362	0.0636	CbGbCtD
Palonosetron—CYP3A4—Dexamethasone—multiple sclerosis	0.023	0.0405	CbGbCtD
Palonosetron—HTR3A—nerve—multiple sclerosis	0.0109	0.0966	CbGeAlD
Palonosetron—HTR3A—brainstem—multiple sclerosis	0.00468	0.0415	CbGeAlD
Palonosetron—HTR3A—nervous system—multiple sclerosis	0.00245	0.0217	CbGeAlD
Palonosetron—HTR3A—central nervous system—multiple sclerosis	0.00236	0.0209	CbGeAlD
Palonosetron—HTR3A—brain—multiple sclerosis	0.00188	0.0166	CbGeAlD
Palonosetron—CYP2D6—brainstem—multiple sclerosis	0.00172	0.0152	CbGeAlD
Palonosetron—CYP3A4—nervous system—multiple sclerosis	0.000917	0.00811	CbGeAlD
Palonosetron—CYP2D6—nervous system—multiple sclerosis	0.000902	0.00798	CbGeAlD
Palonosetron—CYP3A4—central nervous system—multiple sclerosis	0.000882	0.00781	CbGeAlD
Palonosetron—CYP2D6—central nervous system—multiple sclerosis	0.000868	0.00769	CbGeAlD
Palonosetron—CYP2D6—cerebellum—multiple sclerosis	0.000849	0.00751	CbGeAlD
Palonosetron—CYP2D6—brain—multiple sclerosis	0.000689	0.0061	CbGeAlD
Palonosetron—Alopecia—Betamethasone—multiple sclerosis	0.000445	0.0014	CcSEcCtD
Palonosetron—Diarrhoea—Azathioprine—multiple sclerosis	0.000442	0.00139	CcSEcCtD
Palonosetron—Discomfort—Prednisolone—multiple sclerosis	0.000442	0.00139	CcSEcCtD
Palonosetron—Erythema—Betamethasone—multiple sclerosis	0.000438	0.00138	CcSEcCtD
Palonosetron—Erythema—Dexamethasone—multiple sclerosis	0.000438	0.00138	CcSEcCtD
Palonosetron—Connective tissue disorder—Prednisone—multiple sclerosis	0.000431	0.00135	CcSEcCtD
Palonosetron—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000429	0.00135	CcSEcCtD
Palonosetron—Dizziness—Azathioprine—multiple sclerosis	0.000427	0.00134	CcSEcCtD
Palonosetron—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000427	0.00134	CcSEcCtD
Palonosetron—Shock—Prednisolone—multiple sclerosis	0.000422	0.00132	CcSEcCtD
Palonosetron—Convulsion—Triamcinolone—multiple sclerosis	0.000419	0.00131	CcSEcCtD
Palonosetron—Tachycardia—Prednisolone—multiple sclerosis	0.000418	0.00131	CcSEcCtD
Palonosetron—Convulsion—Methylprednisolone—multiple sclerosis	0.000418	0.00131	CcSEcCtD
Palonosetron—Hypertension—Triamcinolone—multiple sclerosis	0.000417	0.00131	CcSEcCtD
Palonosetron—Hypertension—Methylprednisolone—multiple sclerosis	0.000416	0.00131	CcSEcCtD
Palonosetron—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000413	0.0013	CcSEcCtD
Palonosetron—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000413	0.0013	CcSEcCtD
Palonosetron—Myalgia—Triamcinolone—multiple sclerosis	0.000411	0.00129	CcSEcCtD
Palonosetron—Vomiting—Azathioprine—multiple sclerosis	0.000411	0.00129	CcSEcCtD
Palonosetron—Arthralgia—Methylprednisolone—multiple sclerosis	0.00041	0.00129	CcSEcCtD
Palonosetron—Myalgia—Methylprednisolone—multiple sclerosis	0.00041	0.00129	CcSEcCtD
Palonosetron—Eye disorder—Prednisone—multiple sclerosis	0.00041	0.00129	CcSEcCtD
Palonosetron—Anxiety—Methylprednisolone—multiple sclerosis	0.000409	0.00128	CcSEcCtD
Palonosetron—Rash—Azathioprine—multiple sclerosis	0.000408	0.00128	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000407	0.00128	CcSEcCtD
Palonosetron—Dermatitis—Azathioprine—multiple sclerosis	0.000407	0.00128	CcSEcCtD
Palonosetron—Discomfort—Triamcinolone—multiple sclerosis	0.000406	0.00128	CcSEcCtD
Palonosetron—Discomfort—Methylprednisolone—multiple sclerosis	0.000405	0.00127	CcSEcCtD
Palonosetron—Headache—Azathioprine—multiple sclerosis	0.000405	0.00127	CcSEcCtD
Palonosetron—Dry mouth—Triamcinolone—multiple sclerosis	0.000402	0.00126	CcSEcCtD
Palonosetron—Angiopathy—Prednisone—multiple sclerosis	0.000398	0.00125	CcSEcCtD
Palonosetron—Immune system disorder—Prednisone—multiple sclerosis	0.000396	0.00124	CcSEcCtD
Palonosetron—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000394	0.00124	CcSEcCtD
Palonosetron—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000393	0.00123	CcSEcCtD
Palonosetron—Arrhythmia—Prednisone—multiple sclerosis	0.000392	0.00123	CcSEcCtD
Palonosetron—Infection—Triamcinolone—multiple sclerosis	0.000392	0.00123	CcSEcCtD
Palonosetron—Infection—Methylprednisolone—multiple sclerosis	0.000391	0.00123	CcSEcCtD
Palonosetron—Shock—Triamcinolone—multiple sclerosis	0.000388	0.00122	CcSEcCtD
Palonosetron—Insomnia—Prednisolone—multiple sclerosis	0.000388	0.00122	CcSEcCtD
Palonosetron—Alopecia—Prednisone—multiple sclerosis	0.000387	0.00122	CcSEcCtD
Palonosetron—Shock—Methylprednisolone—multiple sclerosis	0.000387	0.00121	CcSEcCtD
Palonosetron—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000386	0.00121	CcSEcCtD
Palonosetron—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000386	0.00121	CcSEcCtD
Palonosetron—Epistaxis—Methotrexate—multiple sclerosis	0.000385	0.00121	CcSEcCtD
Palonosetron—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000385	0.00121	CcSEcCtD
Palonosetron—Paraesthesia—Prednisolone—multiple sclerosis	0.000385	0.00121	CcSEcCtD
Palonosetron—Tachycardia—Triamcinolone—multiple sclerosis	0.000385	0.00121	CcSEcCtD
Palonosetron—Mental disorder—Prednisone—multiple sclerosis	0.000384	0.00121	CcSEcCtD
Palonosetron—Nausea—Azathioprine—multiple sclerosis	0.000384	0.00121	CcSEcCtD
Palonosetron—Tachycardia—Methylprednisolone—multiple sclerosis	0.000384	0.00121	CcSEcCtD
Palonosetron—Skin disorder—Methylprednisolone—multiple sclerosis	0.000382	0.0012	CcSEcCtD
Palonosetron—Malnutrition—Prednisone—multiple sclerosis	0.000382	0.0012	CcSEcCtD
Palonosetron—Erythema—Prednisone—multiple sclerosis	0.000382	0.0012	CcSEcCtD
Palonosetron—Convulsion—Dexamethasone—multiple sclerosis	0.00038	0.00119	CcSEcCtD
Palonosetron—Convulsion—Betamethasone—multiple sclerosis	0.00038	0.00119	CcSEcCtD
Palonosetron—Hypertension—Betamethasone—multiple sclerosis	0.000378	0.00119	CcSEcCtD
Palonosetron—Hypertension—Dexamethasone—multiple sclerosis	0.000378	0.00119	CcSEcCtD
Palonosetron—Asthenia—Mitoxantrone—multiple sclerosis	0.000375	0.00118	CcSEcCtD
Palonosetron—Myalgia—Dexamethasone—multiple sclerosis	0.000373	0.00117	CcSEcCtD
Palonosetron—Myalgia—Betamethasone—multiple sclerosis	0.000373	0.00117	CcSEcCtD
Palonosetron—Anxiety—Dexamethasone—multiple sclerosis	0.000372	0.00117	CcSEcCtD
Palonosetron—Anxiety—Betamethasone—multiple sclerosis	0.000372	0.00117	CcSEcCtD
Palonosetron—Discomfort—Dexamethasone—multiple sclerosis	0.000369	0.00116	CcSEcCtD
Palonosetron—Discomfort—Betamethasone—multiple sclerosis	0.000369	0.00116	CcSEcCtD
Palonosetron—Hypotension—Methylprednisolone—multiple sclerosis	0.000368	0.00115	CcSEcCtD
Palonosetron—Pain—Prednisolone—multiple sclerosis	0.000367	0.00115	CcSEcCtD
Palonosetron—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000362	0.00114	CcSEcCtD
Palonosetron—Urethral disorder—Methotrexate—multiple sclerosis	0.000359	0.00113	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000359	0.00113	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000358	0.00113	CcSEcCtD
Palonosetron—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000358	0.00112	CcSEcCtD
Palonosetron—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000358	0.00112	CcSEcCtD
Palonosetron—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000358	0.00112	CcSEcCtD
Palonosetron—Insomnia—Triamcinolone—multiple sclerosis	0.000357	0.00112	CcSEcCtD
Palonosetron—Insomnia—Methylprednisolone—multiple sclerosis	0.000356	0.00112	CcSEcCtD
Palonosetron—Infection—Dexamethasone—multiple sclerosis	0.000355	0.00112	CcSEcCtD
Palonosetron—Infection—Betamethasone—multiple sclerosis	0.000355	0.00112	CcSEcCtD
Palonosetron—Paraesthesia—Triamcinolone—multiple sclerosis	0.000354	0.00111	CcSEcCtD
Palonosetron—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000353	0.00111	CcSEcCtD
Palonosetron—Anaemia—Prednisone—multiple sclerosis	0.000353	0.00111	CcSEcCtD
Palonosetron—Shock—Dexamethasone—multiple sclerosis	0.000352	0.0011	CcSEcCtD
Palonosetron—Shock—Betamethasone—multiple sclerosis	0.000352	0.0011	CcSEcCtD
Palonosetron—Dyspnoea—Triamcinolone—multiple sclerosis	0.000351	0.0011	CcSEcCtD
Palonosetron—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000351	0.0011	CcSEcCtD
Palonosetron—Nervous system disorder—Betamethasone—multiple sclerosis	0.000351	0.0011	CcSEcCtD
Palonosetron—Tachycardia—Dexamethasone—multiple sclerosis	0.000349	0.0011	CcSEcCtD
Palonosetron—Tachycardia—Betamethasone—multiple sclerosis	0.000349	0.0011	CcSEcCtD
Palonosetron—Dyspepsia—Triamcinolone—multiple sclerosis	0.000347	0.00109	CcSEcCtD
Palonosetron—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000346	0.00109	CcSEcCtD
Palonosetron—Eye disorder—Methotrexate—multiple sclerosis	0.000342	0.00108	CcSEcCtD
Palonosetron—Tinnitus—Methotrexate—multiple sclerosis	0.000342	0.00107	CcSEcCtD
Palonosetron—Anorexia—Dexamethasone—multiple sclerosis	0.000341	0.00107	CcSEcCtD
Palonosetron—Anorexia—Betamethasone—multiple sclerosis	0.000341	0.00107	CcSEcCtD
Palonosetron—Cardiac disorder—Methotrexate—multiple sclerosis	0.00034	0.00107	CcSEcCtD
Palonosetron—Fatigue—Triamcinolone—multiple sclerosis	0.00034	0.00107	CcSEcCtD
Palonosetron—Fatigue—Methylprednisolone—multiple sclerosis	0.000339	0.00106	CcSEcCtD
Palonosetron—Pain—Triamcinolone—multiple sclerosis	0.000337	0.00106	CcSEcCtD
Palonosetron—Hypotension—Betamethasone—multiple sclerosis	0.000334	0.00105	CcSEcCtD
Palonosetron—Hypotension—Dexamethasone—multiple sclerosis	0.000334	0.00105	CcSEcCtD
Palonosetron—Angiopathy—Methotrexate—multiple sclerosis	0.000332	0.00104	CcSEcCtD
Palonosetron—Vomiting—Mitoxantrone—multiple sclerosis	0.000332	0.00104	CcSEcCtD
Palonosetron—Immune system disorder—Methotrexate—multiple sclerosis	0.000331	0.00104	CcSEcCtD
Palonosetron—Convulsion—Prednisone—multiple sclerosis	0.000331	0.00104	CcSEcCtD
Palonosetron—Mediastinal disorder—Methotrexate—multiple sclerosis	0.00033	0.00104	CcSEcCtD
Palonosetron—Hypertension—Prednisone—multiple sclerosis	0.00033	0.00103	CcSEcCtD
Palonosetron—Rash—Mitoxantrone—multiple sclerosis	0.000329	0.00103	CcSEcCtD
Palonosetron—Dermatitis—Mitoxantrone—multiple sclerosis	0.000329	0.00103	CcSEcCtD
Palonosetron—Chills—Methotrexate—multiple sclerosis	0.000329	0.00103	CcSEcCtD
Palonosetron—Headache—Mitoxantrone—multiple sclerosis	0.000327	0.00103	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000326	0.00102	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000326	0.00102	CcSEcCtD
Palonosetron—Myalgia—Prednisone—multiple sclerosis	0.000325	0.00102	CcSEcCtD
Palonosetron—Arthralgia—Prednisone—multiple sclerosis	0.000325	0.00102	CcSEcCtD
Palonosetron—Anxiety—Prednisone—multiple sclerosis	0.000324	0.00102	CcSEcCtD
Palonosetron—Alopecia—Methotrexate—multiple sclerosis	0.000324	0.00102	CcSEcCtD
Palonosetron—Insomnia—Dexamethasone—multiple sclerosis	0.000324	0.00102	CcSEcCtD
Palonosetron—Insomnia—Betamethasone—multiple sclerosis	0.000324	0.00102	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000323	0.00101	CcSEcCtD
Palonosetron—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000322	0.00101	CcSEcCtD
Palonosetron—Paraesthesia—Betamethasone—multiple sclerosis	0.000321	0.00101	CcSEcCtD
Palonosetron—Paraesthesia—Dexamethasone—multiple sclerosis	0.000321	0.00101	CcSEcCtD
Palonosetron—Discomfort—Prednisone—multiple sclerosis	0.000321	0.00101	CcSEcCtD
Palonosetron—Mental disorder—Methotrexate—multiple sclerosis	0.000321	0.00101	CcSEcCtD
Palonosetron—Malnutrition—Methotrexate—multiple sclerosis	0.000319	0.001	CcSEcCtD
Palonosetron—Erythema—Methotrexate—multiple sclerosis	0.000319	0.001	CcSEcCtD
Palonosetron—Hypersensitivity—Prednisolone—multiple sclerosis	0.000316	0.000992	CcSEcCtD
Palonosetron—Dyspepsia—Dexamethasone—multiple sclerosis	0.000315	0.000989	CcSEcCtD
Palonosetron—Dyspepsia—Betamethasone—multiple sclerosis	0.000315	0.000989	CcSEcCtD
Palonosetron—Dysgeusia—Methotrexate—multiple sclerosis	0.000312	0.000981	CcSEcCtD
Palonosetron—Body temperature increased—Triamcinolone—multiple sclerosis	0.000312	0.000978	CcSEcCtD
Palonosetron—Anaphylactic shock—Prednisone—multiple sclerosis	0.000312	0.000978	CcSEcCtD
Palonosetron—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000311	0.000976	CcSEcCtD
Palonosetron—Decreased appetite—Dexamethasone—multiple sclerosis	0.000311	0.000976	CcSEcCtD
Palonosetron—Decreased appetite—Betamethasone—multiple sclerosis	0.000311	0.000976	CcSEcCtD
Palonosetron—Nausea—Mitoxantrone—multiple sclerosis	0.00031	0.000974	CcSEcCtD
Palonosetron—Infection—Prednisone—multiple sclerosis	0.000309	0.000972	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000309	0.00097	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000309	0.00097	CcSEcCtD
Palonosetron—Fatigue—Dexamethasone—multiple sclerosis	0.000308	0.000968	CcSEcCtD
Palonosetron—Fatigue—Betamethasone—multiple sclerosis	0.000308	0.000968	CcSEcCtD
Palonosetron—Shock—Prednisone—multiple sclerosis	0.000306	0.000962	CcSEcCtD
Palonosetron—Pain—Betamethasone—multiple sclerosis	0.000306	0.00096	CcSEcCtD
Palonosetron—Pain—Dexamethasone—multiple sclerosis	0.000306	0.00096	CcSEcCtD
Palonosetron—Nervous system disorder—Prednisone—multiple sclerosis	0.000305	0.000959	CcSEcCtD
Palonosetron—Tachycardia—Prednisone—multiple sclerosis	0.000304	0.000954	CcSEcCtD
Palonosetron—Skin disorder—Prednisone—multiple sclerosis	0.000303	0.00095	CcSEcCtD
Palonosetron—Anorexia—Prednisone—multiple sclerosis	0.000297	0.000932	CcSEcCtD
Palonosetron—Anaemia—Methotrexate—multiple sclerosis	0.000295	0.000926	CcSEcCtD
Palonosetron—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000292	0.000918	CcSEcCtD
Palonosetron—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000292	0.000918	CcSEcCtD
Palonosetron—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00029	0.000912	CcSEcCtD
Palonosetron—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00029	0.00091	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000284	0.000891	CcSEcCtD
Palonosetron—Dizziness—Prednisolone—multiple sclerosis	0.000283	0.00089	CcSEcCtD
Palonosetron—Asthenia—Triamcinolone—multiple sclerosis	0.000283	0.000888	CcSEcCtD
Palonosetron—Abdominal pain—Betamethasone—multiple sclerosis	0.000283	0.000888	CcSEcCtD
Palonosetron—Body temperature increased—Dexamethasone—multiple sclerosis	0.000283	0.000888	CcSEcCtD
Palonosetron—Body temperature increased—Betamethasone—multiple sclerosis	0.000283	0.000888	CcSEcCtD
Palonosetron—Abdominal pain—Dexamethasone—multiple sclerosis	0.000283	0.000888	CcSEcCtD
Palonosetron—Asthenia—Methylprednisolone—multiple sclerosis	0.000282	0.000886	CcSEcCtD
Palonosetron—Insomnia—Prednisone—multiple sclerosis	0.000282	0.000885	CcSEcCtD
Palonosetron—Paraesthesia—Prednisone—multiple sclerosis	0.00028	0.000878	CcSEcCtD
Palonosetron—Pruritus—Triamcinolone—multiple sclerosis	0.000279	0.000876	CcSEcCtD
Palonosetron—Pruritus—Methylprednisolone—multiple sclerosis	0.000278	0.000874	CcSEcCtD
Palonosetron—Convulsion—Methotrexate—multiple sclerosis	0.000276	0.000868	CcSEcCtD
Palonosetron—Dyspepsia—Prednisone—multiple sclerosis	0.000274	0.000861	CcSEcCtD
Palonosetron—Arthralgia—Methotrexate—multiple sclerosis	0.000272	0.000853	CcSEcCtD
Palonosetron—Myalgia—Methotrexate—multiple sclerosis	0.000272	0.000853	CcSEcCtD
Palonosetron—Decreased appetite—Prednisone—multiple sclerosis	0.000271	0.00085	CcSEcCtD
Palonosetron—Rash—Prednisolone—multiple sclerosis	0.00027	0.000849	CcSEcCtD
Palonosetron—Dermatitis—Prednisolone—multiple sclerosis	0.00027	0.000848	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00027	0.000847	CcSEcCtD
Palonosetron—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000269	0.000845	CcSEcCtD
Palonosetron—Fatigue—Prednisone—multiple sclerosis	0.000269	0.000843	CcSEcCtD
Palonosetron—Headache—Prednisolone—multiple sclerosis	0.000269	0.000843	CcSEcCtD
Palonosetron—Discomfort—Methotrexate—multiple sclerosis	0.000268	0.000842	CcSEcCtD
Palonosetron—Constipation—Prednisone—multiple sclerosis	0.000266	0.000836	CcSEcCtD
Palonosetron—Dizziness—Triamcinolone—multiple sclerosis	0.000261	0.000818	CcSEcCtD
Palonosetron—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00026	0.000817	CcSEcCtD
Palonosetron—Dizziness—Methylprednisolone—multiple sclerosis	0.00026	0.000817	CcSEcCtD
Palonosetron—Infection—Methotrexate—multiple sclerosis	0.000259	0.000812	CcSEcCtD
Palonosetron—Asthenia—Dexamethasone—multiple sclerosis	0.000257	0.000806	CcSEcCtD
Palonosetron—Asthenia—Betamethasone—multiple sclerosis	0.000257	0.000806	CcSEcCtD
Palonosetron—Nervous system disorder—Methotrexate—multiple sclerosis	0.000255	0.000802	CcSEcCtD
Palonosetron—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000255	0.0008	CcSEcCtD
Palonosetron—Nausea—Prednisolone—multiple sclerosis	0.000255	0.000799	CcSEcCtD
Palonosetron—Pruritus—Betamethasone—multiple sclerosis	0.000253	0.000795	CcSEcCtD
Palonosetron—Pruritus—Dexamethasone—multiple sclerosis	0.000253	0.000795	CcSEcCtD
Palonosetron—Skin disorder—Methotrexate—multiple sclerosis	0.000253	0.000794	CcSEcCtD
Palonosetron—Vomiting—Triamcinolone—multiple sclerosis	0.000251	0.000787	CcSEcCtD
Palonosetron—Vomiting—Methylprednisolone—multiple sclerosis	0.00025	0.000785	CcSEcCtD
Palonosetron—Rash—Triamcinolone—multiple sclerosis	0.000249	0.00078	CcSEcCtD
Palonosetron—Dermatitis—Triamcinolone—multiple sclerosis	0.000248	0.00078	CcSEcCtD
Palonosetron—Anorexia—Methotrexate—multiple sclerosis	0.000248	0.000779	CcSEcCtD
Palonosetron—Rash—Methylprednisolone—multiple sclerosis	0.000248	0.000779	CcSEcCtD
Palonosetron—Dermatitis—Methylprednisolone—multiple sclerosis	0.000248	0.000778	CcSEcCtD
Palonosetron—Headache—Triamcinolone—multiple sclerosis	0.000247	0.000775	CcSEcCtD
Palonosetron—Headache—Methylprednisolone—multiple sclerosis	0.000246	0.000774	CcSEcCtD
Palonosetron—Abdominal pain—Prednisone—multiple sclerosis	0.000246	0.000773	CcSEcCtD
Palonosetron—Body temperature increased—Prednisone—multiple sclerosis	0.000246	0.000773	CcSEcCtD
Palonosetron—Diarrhoea—Betamethasone—multiple sclerosis	0.000245	0.000768	CcSEcCtD
Palonosetron—Diarrhoea—Dexamethasone—multiple sclerosis	0.000245	0.000768	CcSEcCtD
Palonosetron—Hypotension—Methotrexate—multiple sclerosis	0.000243	0.000764	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000237	0.000745	CcSEcCtD
Palonosetron—Dizziness—Dexamethasone—multiple sclerosis	0.000237	0.000743	CcSEcCtD
Palonosetron—Dizziness—Betamethasone—multiple sclerosis	0.000237	0.000743	CcSEcCtD
Palonosetron—Insomnia—Methotrexate—multiple sclerosis	0.000235	0.000739	CcSEcCtD
Palonosetron—Nausea—Triamcinolone—multiple sclerosis	0.000234	0.000735	CcSEcCtD
Palonosetron—Paraesthesia—Methotrexate—multiple sclerosis	0.000234	0.000734	CcSEcCtD
Palonosetron—Nausea—Methylprednisolone—multiple sclerosis	0.000234	0.000734	CcSEcCtD
Palonosetron—Dyspnoea—Methotrexate—multiple sclerosis	0.000232	0.000729	CcSEcCtD
Palonosetron—Somnolence—Methotrexate—multiple sclerosis	0.000231	0.000727	CcSEcCtD
Palonosetron—Hypersensitivity—Prednisone—multiple sclerosis	0.00023	0.000721	CcSEcCtD
Palonosetron—Dyspepsia—Methotrexate—multiple sclerosis	0.000229	0.000719	CcSEcCtD
Palonosetron—Vomiting—Dexamethasone—multiple sclerosis	0.000227	0.000714	CcSEcCtD
Palonosetron—Vomiting—Betamethasone—multiple sclerosis	0.000227	0.000714	CcSEcCtD
Palonosetron—Decreased appetite—Methotrexate—multiple sclerosis	0.000226	0.00071	CcSEcCtD
Palonosetron—Rash—Betamethasone—multiple sclerosis	0.000226	0.000708	CcSEcCtD
Palonosetron—Rash—Dexamethasone—multiple sclerosis	0.000226	0.000708	CcSEcCtD
Palonosetron—Dermatitis—Dexamethasone—multiple sclerosis	0.000225	0.000707	CcSEcCtD
Palonosetron—Dermatitis—Betamethasone—multiple sclerosis	0.000225	0.000707	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000225	0.000706	CcSEcCtD
Palonosetron—Fatigue—Methotrexate—multiple sclerosis	0.000224	0.000705	CcSEcCtD
Palonosetron—Headache—Dexamethasone—multiple sclerosis	0.000224	0.000704	CcSEcCtD
Palonosetron—Headache—Betamethasone—multiple sclerosis	0.000224	0.000704	CcSEcCtD
Palonosetron—Asthenia—Prednisone—multiple sclerosis	0.000223	0.000702	CcSEcCtD
Palonosetron—Pain—Methotrexate—multiple sclerosis	0.000223	0.000699	CcSEcCtD
Palonosetron—Pruritus—Prednisone—multiple sclerosis	0.00022	0.000692	CcSEcCtD
Palonosetron—Diarrhoea—Prednisone—multiple sclerosis	0.000213	0.000669	CcSEcCtD
Palonosetron—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000213	0.000668	CcSEcCtD
Palonosetron—Nausea—Betamethasone—multiple sclerosis	0.000212	0.000667	CcSEcCtD
Palonosetron—Nausea—Dexamethasone—multiple sclerosis	0.000212	0.000667	CcSEcCtD
Palonosetron—Dizziness—Prednisone—multiple sclerosis	0.000206	0.000647	CcSEcCtD
Palonosetron—Body temperature increased—Methotrexate—multiple sclerosis	0.000206	0.000646	CcSEcCtD
Palonosetron—Abdominal pain—Methotrexate—multiple sclerosis	0.000206	0.000646	CcSEcCtD
Palonosetron—Vomiting—Prednisone—multiple sclerosis	0.000198	0.000622	CcSEcCtD
Palonosetron—Rash—Prednisone—multiple sclerosis	0.000196	0.000617	CcSEcCtD
Palonosetron—Dermatitis—Prednisone—multiple sclerosis	0.000196	0.000616	CcSEcCtD
Palonosetron—Headache—Prednisone—multiple sclerosis	0.000195	0.000613	CcSEcCtD
Palonosetron—Hypersensitivity—Methotrexate—multiple sclerosis	0.000192	0.000602	CcSEcCtD
Palonosetron—Asthenia—Methotrexate—multiple sclerosis	0.000187	0.000586	CcSEcCtD
Palonosetron—Nausea—Prednisone—multiple sclerosis	0.000185	0.000581	CcSEcCtD
Palonosetron—Pruritus—Methotrexate—multiple sclerosis	0.000184	0.000578	CcSEcCtD
Palonosetron—Diarrhoea—Methotrexate—multiple sclerosis	0.000178	0.000559	CcSEcCtD
Palonosetron—Dizziness—Methotrexate—multiple sclerosis	0.000172	0.00054	CcSEcCtD
Palonosetron—Vomiting—Methotrexate—multiple sclerosis	0.000166	0.00052	CcSEcCtD
Palonosetron—Rash—Methotrexate—multiple sclerosis	0.000164	0.000515	CcSEcCtD
Palonosetron—Dermatitis—Methotrexate—multiple sclerosis	0.000164	0.000515	CcSEcCtD
Palonosetron—Headache—Methotrexate—multiple sclerosis	0.000163	0.000512	CcSEcCtD
Palonosetron—Nausea—Methotrexate—multiple sclerosis	0.000155	0.000485	CcSEcCtD
